The Latest Headlines at American Banking and Market News
Vitro Diagnostics (OTCMKTS:VODG) & Quince Therapeutics (NASDAQ:QNCX) Critical Contrast
Vitro Diagnostics (OTCMKTS:VODG – Get Free Report) and Quince Therapeutics (NASDAQ:QNCX – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the... More of this article »
Comparing Barratt Developments (OTCMKTS:BTDPF) & M.D.C. (NYSE:MDC)
M.D.C. (NYSE:MDC – Get Free Report) and Barratt Developments (OTCMKTS:BTDPF – Get Free Report) are both consumer cyclical companies, but which is the superior stock? We will contrast the two companies based on the strength... More of this article »
Contrasting Alnylam Pharmaceuticals (NASDAQ:ALNY) & TFF Pharmaceuticals (NASDAQ:TFFP)
TFF Pharmaceuticals (NASDAQ:TFFP – Get Free Report) and Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based... More of this article »
Critical Contrast: The Hartford Financial Services Group (NYSE:HIG) and Hamilton Insurance Group (NYSE:HG)
The Hartford Financial Services Group (NYSE:HIG – Get Free Report) and Hamilton Insurance Group (NYSE:HG – Get Free Report) are both finance companies, but which is the superior investment? We will compare the two companies... More of this article »
Nuveen Churchill Direct Lending (NYSE:NCDL) vs. Ocwen Financial (NYSE:OCN) Financial Comparison
Ocwen Financial (NYSE:OCN – Get Free Report) and Nuveen Churchill Direct Lending (NYSE:NCDL – Get Free Report) are both small-cap finance companies, but which is the superior stock? We will contrast the two businesses based... More of this article »
Brokerages Set Blue Owl Capital Co. (NYSE:OBDC) PT at $15.50
Shares of Blue Owl Capital Co. (NYSE:OBDC – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the six brokerages that are presently covering the firm, MarketBeat.com reports. One... More of this article »
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives $55.60 Consensus PT from Analysts
Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) have been given an average rating of “Buy” by the six research firms that are currently covering the firm, Marketbeat.com reports. Six investment... More of this article »
Analysts Set Savers Value Village, Inc. (NYSE:SVV) PT at $27.63
Savers Value Village, Inc. (NYSE:SVV – Get Free Report) has received a consensus rating of “Buy” from the nine ratings firms that are covering the company, MarketBeat.com reports. Nine research analysts have rated... More of this article »
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Receives $8.00 Consensus PT from Brokerages
Shares of Aquestive Therapeutics, Inc. (NASDAQ:AQST – Get Free Report) have been given an average rating of “Buy” by the six research firms that are presently covering the firm, MarketBeat Ratings reports. Six equities... More of this article »
Zacks Research Brokers Lower Earnings Estimates for Tractor Supply (NASDAQ:TSCO)
Tractor Supply (NASDAQ:TSCO – Free Report) – Stock analysts at Zacks Research decreased their Q2 2024 earnings per share (EPS) estimates for shares of Tractor Supply in a report released on Thursday, May 9th. Zacks... More of this article »
Principal Financial Group, Inc. (NYSE:PFG) Receives Consensus Recommendation of “Reduce” from Analysts
Shares of Principal Financial Group, Inc. (NYSE:PFG – Get Free Report) have earned a consensus recommendation of “Reduce” from the ten analysts that are covering the stock, Marketbeat Ratings reports. Two investment... More of this article »
Analysts Set Amicus Therapeutics, Inc. (NASDAQ:FOLD) Price Target at $20.00
Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Free Report) have received an average rating of “Moderate Buy” from the six brokerages that are covering the firm, MarketBeat.com reports. One research analyst... More of this article »
Genco Shipping & Trading Limited (NYSE:GNK) Receives $25.00 Consensus PT from Brokerages
Shares of Genco Shipping & Trading Limited (NYSE:GNK – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the four research firms that are presently covering the stock, MarketBeat.com... More of this article »